Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?

by Savitha C Muppala on  December 18, 2006 at 4:11 PM Drug News   - G J E 4
Did Eli Lilly Turn Wily With Regard to Their Best-selling Schizophrenia Drug?
Eli Lilly, the pharmaceutical company, is in a tight spot, defending its position against the law suits from mentally ill patients, about the company's best-selling schizophrenia drug, Zyprexa. The company is being blamed for undermining the health risks of the drug, which is being linked to obesity and high blood sugar.

On the basis of many supporting documents and internal communication between managers in the company, ample evidence has surfaced, that the company has indeed kept under wraps, the harmful side-effects of the drug Zyprexa.

Even the company's published statistics which the sales representatives have been tutored to make light of, portrays statistics that about 30% of the patients consuming Zyprexa, have gained 22 pounds within a year of consuming the drug and some have gained as much as 100 pounds. The documents clearly portray the abiding worry of the company that its sales might plummet if they were honest about the drug's effect on weight gain or blood sugar levels.

The company has not taken the allegation lightly and has completely denied it. Lilly explained that the FDA has been enabled with a clear picture of all the clinical trials and reviews regarding the usage of the drug world-wide. But documents in circulation within the company relates to an entirely different story. Apprehension regarding the drug's side effects has been debated as early as 1999, to the extent that company bigwigs felt it could jeopardize the sales of their most popular product, if it were publicized.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
What's strange is that if you visit the Eli Lilly website. The main message on their homepage is about investments and cash generation. These guys are not interested in health. It's all about money and they are obsessed about it.
guest Wednesday, December 20, 2006
Eli Lilly ZYPREXA LIES! Zyprexa off label promotion scandal is all over the news now. Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa". Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups. So how does Zyprexa get to be the 7th largest drug sale in the world? Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses. The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution. Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco. --- Daniel Haszard
guest Monday, December 18, 2006

You May Also Like

View All